https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-10-19 / Methods Cell Biol 2024;183:51-113
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-10-19 / Methods Cell Biol 2024;183:51-1132023-10-19 00:00:002024-04-20 10:47:17Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-02-22 / Cancers (Basel) 2023 Feb;15(5)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-02-22 / Cancers (Basel) 2023 Feb;15(5)2023-02-22 00:00:002023-02-22 00:00:00From Localized Mild Hyperthermia to Improved Tumor Oxygenation: Physiological Mechanisms Critically Involved in Oncologic Thermo-Radio-Immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-01-20 / Medicine (Baltimore) 2023 Jan;102(3):e32727
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-01-20 / Medicine (Baltimore) 2023 Jan;102(3):e327272023-01-20 00:00:002023-02-11 09:54:47Modulated electrohyperthermia in locally advanced cervical cancer: Results of an observational study of 95 patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-10-14 / Clin Exp Med 2022 Nov;22(4):667-672
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-10-14 / Clin Exp Med 2022 Nov;22(4):667-6722022-10-14 00:00:002022-10-14 00:00:00Commentary on „Systematic review about complementary medical hyperthermia in oncology“ by Liebl et al
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-06-04 / Cells 2022 Jun;11(11)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-06-04 / Cells 2022 Jun;11(11)2022-06-04 00:00:002022-06-04 00:00:00Forcing the Antitumor Effects of HSPs Using a Modulated Electric Field
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-03-01 / Cancers (Basel) 2022 Mar;14(5)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-03-01 / Cancers (Basel) 2022 Mar;14(5)2022-03-01 00:00:002022-03-01 00:00:00Long-Term Feasibility of 13.56 MHz Modulated Electro-Hyperthermia-Based Preoperative Thermoradiochemotherapy in Locally Advanced Rectal Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-02-16 / Genes Immun 2022 Feb;
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-02-16 / Genes Immun 2022 Feb;2022-02-16 00:00:002022-02-21 07:49:56Synergy between TMZ and individualized multimodal immunotherapy to improve overall survival of IDH1 wild-type MGMT promoter-unmethylated GBM patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2022-01-27 / Cancers (Basel) 2022 Jan;14(3)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2022-01-27 / Cancers (Basel) 2022 Jan;14(3)2022-01-27 00:00:002024-02-05 11:28:29Effects of Modulated Electro-Hyperthermia (mEHT) on Two and Three Year Survival of Locally Advanced Cervical Cancer Patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-12-10 / Pathol Oncol Res 2021;27:1610048
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-12-10 / Pathol Oncol Res 2021;27:16100482021-12-10 00:00:002021-12-10 00:00:00Modulated Electro-Hyperthermia Supports the Effect of Gemcitabine Both in Sensitive and Resistant Pancreas Adenocarcinoma Cell Lines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-11-24 / World J Clin Oncol 2021 Nov;12(11):1064-1071
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-11-24 / World J Clin Oncol 2021 Nov;12(11):1064-10712021-11-24 00:00:002021-11-24 00:00:00Modulated electro-hyperthermia in stage III and IV pancreatic cancer: Results of an observational study on 158 patients
